The AHA’s Health Research & Educational Trust affiliate and the Centers for Disease Control and Prevention today announced a three-year initiative to improve the implementation of infection prevention and control efforts in U.S. hospitals. The project will work with state hospital associations, state health departments, the Centers for Medicare & Medicaid Services’ Quality Improvement Networks, AHA’s American Society for Healthcare Engineering affiliate and other partners to reduce central line-associated bloodstream infections, catheter-associated urinary tract infections, Clostridium difficile infections and methicillin-resistant Staphylococcus aureus infections in targeted acute care hospitals. “We welcome the opportunity to work with CDC on the important issue of infection prevention,” said Maulik Joshi, president of HRET and associate executive vice president of AHA. “This project will build on our national work that has successfully reduced CAUTI and CLABSI rates and improved patient care.”

Related News Articles

Headline
The AHA’s social media toolkit for spreading awareness of the flu focuses on the beginning of fall and the availability of the flu vaccine for at-risk,…
Headline
Measles cases have been reported by 42 states and jurisdictions this year, with 1,563 total nationwide, according to the latest data released yesterday by the…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
AHA’s latest social media toolkit for spreading awareness of the flu focuses on the availability of the flu vaccine for at-risk, vulnerable populations as flu…
Headline
The Centers for Disease Control and Prevention Sept. 24 released its annual report on national sexually transmitted disease data, reporting a 9% decline in STD…
Headline
The Food and Drug Administration released a final rule Sept. 18 that rescinds one from 2024 that applied medical device rules to laboratory-developed tests.…